Beutel, Goodman & Co’s NeoGenomics NEO Stock Holding History

Beutel, Goodman & Co’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	50	–	–	﹤0.01%	164
2026 Q1	$0	Hold	50	–	–	﹤0.01%	176
2025 Q4	$0	Hold	50	–	–	﹤0.01%	175
2025 Q3	$0	Hold	50	–	–	﹤0.01%	179
2025 Q2	$0	Hold	50	–	–	﹤0.01%	193
2025 Q1	$0	Buy	+50	New	+$624	﹤0.01%	206

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Beutel, Goodman & Co's NEO Position: Q2 2026 in Review

Beutel, Goodman & Co held its NeoGenomics (NEO) position steady in Q2 2026 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #164.

Beutel, Goodman & Co first reported a position in NEO in Q1 2025 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Beutel, Goodman & Co held 50 shares of NeoGenomics worth $0 as of Q2 2026.
Beutel, Goodman & Co left its NeoGenomics share count unchanged in Q2 2026.
NeoGenomics made up ﹤0.01% of Beutel, Goodman & Co's portfolio in Q2 2026, its #164 holding.
Beutel, Goodman & Co first reported a position in NeoGenomics in Q1 2025 and has held it in 6 quarters since.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Beutel, Goodman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.